PSNL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Personalis Inc (PSNL) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown some positive financial growth trends, the significant pre-market drop of -9.30% and lack of strong trading signals suggest caution. The technical indicators are neutral, and there are no clear catalysts to drive immediate gains. Holding off for more favorable conditions or further clarity on the company's performance is recommended.
The MACD is positive and expanding, indicating a potential upward trend. However, RSI is neutral at 63.861, and moving averages are converging, suggesting no clear directional momentum. The stock is trading near its pivot level of 8.637, with support at 7.975 and resistance at 9.299.
Personalis delivered 6,183 clinical tests in Q4, reflecting a 41% sequential growth. Revenue for Q4 2025 increased by 3.24% YoY, and the company projects 2026 revenue to grow further to $78-$80 million.
The pre-market price drop of -9.30% indicates negative sentiment. Gross margin dropped significantly by -59.56% YoY, and the company remains unprofitable with a net income of -$23.81 million in Q4 2025.
In Q4 2025, revenue increased by 3.24% YoY to $17.35 million. Net income improved by 44.97% YoY but remains negative at -$23.81 million. EPS improved to -$0.26, up 13.04% YoY. However, gross margin dropped significantly to 10.95%, down -59.56% YoY.
Guggenheim raised the price target to $13 from $12 and maintained a Buy rating, reflecting optimism in the company's long-term potential. However, there are no recent upgrades or significant changes in sentiment.
